MMedication Read More Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in StudyNovember 6, 2025 Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
HHealthcare Read More Metsera calls Novo Nordisk’s new bid superior to Pfizer offerNovember 4, 2025 The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
HHealthcare Read More Pfizer files second lawsuit against Novo Nordisk, MetseraNovember 3, 2025 A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
HHealthcare Read More Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidNovember 1, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
HHealthcare Read More Pfizer’s new obesity bet, Metsera, releases drug dataSeptember 30, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in…